Pacira Biosciences, Inc. (PCRX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on July 3, 2025, by Pacira Biosciences, Inc., a Delaware corporation. The report details the entry into a new material definitive agreement to refinance existing indebtedness and secure ongoing working capital.
Key Financial Metrics and Debt Structure
The filing focuses on debt restructuring rather than operational financial performance metrics such as revenue or profit, which are not provided in this document.
- New Facility: Senior secured revolving credit facility with an aggregate commitment of $300.0 million.
- Sublimits: Includes a $10.0 million letter of credit sublimit and a $15.0 million swingline loan sublimit.
- Maturity Date: July 3, 2030.
- Collateral: Secured by substantially all assets of the Company and subsidiary guarantors.
- Interest Rates:
- Alternate Base Rate Borrowings: Base rate plus a spread of 1.50% to 2.25% based on Senior Secured Net Leverage Ratio.
- SOFR Borrowings: Forward-looking term rate or daily simple SOFR plus a spread of 2.50% to 3.25% based on Senior Secured Net Leverage Ratio.
- Incremental Capacity: The Company may request incremental term facilities up to the greater of $225.0 million or 100% of Consolidated EBITDA.
Material Changes Versus Prior Period
On July 3, 2025, the Company utilized a portion of the new $300.0 million revolving loans to repay all indebtedness outstanding under the Existing Credit Agreement (dated March 31, 2023, as amended). Consequently, the Existing Credit Agreement was terminated. The Company incurred no prepayment penalties or fees associated with this termination.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard covenants inherent in the new Credit Agreement. The agreement includes customary affirmative and negative covenants, financial covenants, representations, warranties, and events of default.
Key Facts for Investor Verification
- Verify the Company's current Senior Secured Net Leverage Ratio to determine the applicable interest rate spread.
- Review the full text of the Credit Agreement (Exhibit 10.1) for specific financial covenants and events of default.
- Confirm the exact amount drawn from the new facility to repay the old debt versus the remaining available liquidity.
- Monitor future filings for any utilization of the incremental term facility option.